RE104 Safety and Efficacy Study in Generalized Anxiety Disorder

NCT ID
NCT07489651
Registry status
Recruiting
Study type
Interventional
Phase
Phase 2
Sponsor
Reunion Neuroscience Inc
Conditions
Generalized Anxiety Disorder

Overview

ClinicalTrials.gov lists this study as Recruiting.

Official title: A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of RE104 for Injection in the Treatment of Generalized Anxiety Disorder

Enrollment: 160 participants (Estimated).

What is being studied

  • Intervention: Drug Administration Routes
  • Intervention: Drug Therapy
  • Intervention: Injections
  • Drug: Placebo
  • Drug: RE104 for Injection
  • Intervention: Therapeutics

Who may be eligible

Ages
18 Years to 74 Years
Sex
All
Healthy volunteers accepted
No

ClinicalTrials.gov lists the following eligibility criteria.

Inclusion Criteria: * Has Generalized Anxiety Disorder as defined by DSM-5-TR * If female is not pregnant or planning to become pregnant. If male is not planning to make a partner pregnant. * Is willing and able to comply with the conditions and requirements of the study Exclusion Criteria: * Has a significant risk of suicide * Has an active or medical history of bipolar disorder, schizophrenia, schizoaffective disorder, psychotic disorder and/or borderline personality disorder, or first-degree family history of psychosis or bipolar disorder * Has other concurrent psychiatric disorders that is the primary disorder. * Has other medically significant conditions rendering unsuitability for the study * Has used or will need to use prohibited medications or therapies * Has a known sensitivity or intolerance to study intervention or potential rescue medications

Study locations

28 study locations are listed.

Recruiting site status is explicitly provided for 28 locations; 27 are listed as Recruiting.

Countries: United States

  • Alabama, United States: 1
  • Arizona, United States: 1
  • Arkansas, United States: 1
  • California, United States: 4
  • Florida, United States: 2
  • Georgia, United States: 4
  • Illinois, United States: 1
  • Michigan, United States: 1
  • Missouri, United States: 1
  • New Mexico, United States: 1
  • New York, United States: 1
  • North Carolina, United States: 1
  • Ohio, United States: 1
  • Oregon, United States: 1
  • Pennsylvania, United States: 2
  • Texas, United States: 3
  • Utah, United States: 2

Sample of listed locations

  • University of Alabama (UAB) Clinical Research Unit (CRU) — Birmingham, Alabama, 35209, United States — Recruiting
  • Lighthouse Psychiatry — Gilbert, Arizona, 85234, United States — Recruiting
  • Preferred Research Partners, Inc. — Little Rock, Arkansas, 72211, United States — Recruiting
  • Collaborative Neuroscience Research, LLC — Garden Grove, California, 92845, United States — Recruiting
  • Kadima Neuropsychiatry Institute — La Jolla, California, 92037, United States — Recruiting
  • Open Mind Therapeutics — San Francisco, California, 94114, United States — Recruiting
  • TRIP Clinic at Psychedelic Science Institute — Santa Monica, California, 90404, United States — Recruiting
  • Innovative Clinical Research, Inc. — Lauderhill, Florida, 33319, United States — Recruiting
  • University of South Florida — Tampa, Florida, 33613, United States — Recruiting
  • Atlanta Center for Medical Research — Atlanta, Georgia, 30331, United States — Recruiting
  • CenExel iResearch, LLC — Decatur, Georgia, 30030, United States — Recruiting
  • Evergreen Clinical Trials — Norcross, Georgia, 30092, United States — Recruiting
  • CenExel iResearch, LLC — Savannah, Georgia, 31405, United States — Recruiting
  • Uptown Research Institute — Chicago, Illinois, 60640, United States — Recruiting
  • Henry Ford Medical Center - Columbus — Novi, Michigan, 48377, United States — Recruiting
  • Midwest Research Group — Saint Charles, Missouri, 63304, United States — Recruiting
  • UNM Research Program Psychedelic Therapies — Albuquerque, New Mexico, 14624, United States — Recruiting
  • NYU-H+C Clinical and Translational Science Institute — New York, New York, 10016, United States — Recruiting
  • University of North Carolina at Chapel Hill — Chapel Hill, North Carolina, 27514, United States — Recruiting
  • Neuro-Behavioral Clinical Research, Inc. — North Canton, Ohio, 44720, United States — Recruiting
  • Summit Headlands LLC — Portland, Oregon, 97210, United States — Recruiting
  • University of Pennsylvania — Philadelphia, Pennsylvania, 19104, United States — Recruiting
  • Austin Clinical Trial Partners — Austin, Texas, 78737, United States — Recruiting
  • BioBehavioral Research Austion — Austin, Texas, 78759, United States — Recruiting
  • Aim Trials, LLC — Plano, Texas, 75093, United States — Recruiting

Study details

Start date
April 20, 2026
Primary completion date
July 1, 2027
Completion date
September 1, 2027
First posted
March 24, 2026

Source and update information

Source
ClinicalTrials.gov
NCT ID
NCT07489651
Registry last updated
September 24, 2026
QualifiedStudies registry data refreshed
September 28, 2026
QualifiedStudies record fetched
September 28, 2026

View NCT07489651 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Clinical trial FAQ